Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Accelerated TMS in Psychosis

NCT: NCT05567848 · SUSPENDED

NCT IDNCT05567848
StatusSUSPENDED
Start Date2022-11-29
Completion2027-01

Brief Summary

This study is to determine the tolerability and efficacy of an accelerated schedule of Transcranial Magnetic Stimulation for treating symptoms of psychotic disorders such as schizophrenia.

Frequently Asked Questions

What is Accelerated TMS in Psychosis?

Accelerated TMS in Psychosis is a clinical trial registered under NCT05567848. Current status: SUSPENDED.

What is the status of NCT05567848?

The current status of NCT05567848 (Accelerated TMS in Psychosis) is: SUSPENDED.

When did Accelerated TMS in Psychosis start?

Accelerated TMS in Psychosis started on 2022-11-29.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑